Title: InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278): A Powerful Tool for Hepatitis E Virus Research
Are you looking for a reliable and effective antibody for your Hepatitis E virus (HEV) research? Look no further than InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278). This highly specific and potent antibody is designed to target the pORF2 P domain of the HEV virus, making it an essential tool for any researcher studying HEV.
Biological Function:
The pORF2 P domain is a crucial component of the HEV virus, responsible for viral attachment, entry, and fusion with host cells. By targeting this domain, InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278) effectively blocks the virus from entering host cells, preventing viral replication and spread.
Main Applications:
InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278) has a wide range of applications in HEV research. It can be used for in vitro studies to understand the virus’s mechanisms of action, as well as in vivo studies to evaluate the antibody’s efficacy in blocking HEV infection. This antibody is also valuable in diagnostic assays for detecting HEV infections.
Experimental Use Cases:
InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278) has been extensively tested and validated for its effectiveness in multiple experimental use cases. It has shown promising results in blocking HEV infection in cell culture and animal models, making it a reliable tool for studying the virus’s pathogenesis and developing potential treatments.
Our InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278) is a potent and specific antibody that targets the pORF2 P domain of the HEV virus. It is ideal for in vitro and in vivo studies, as well as diagnostic assays. This antibody has been extensively tested and validated for its effectiveness in blocking HEV infection in various experimental models.
In conclusion, InVivoMAb Anti-Hepatitis E Virus/HEV pORF2 P Domain Neutralizing Antibody (Iv0278) is a powerful tool for HEV research, with its ability to specifically target the pORF2 P domain of the virus. Its wide range of applications and proven efficacy in experimental use cases make it a valuable asset for any researcher studying HEV. Order now and take your HEV research to the next level.
There are no reviews yet.